Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Videoconferencing | 3 | 2019 | 20 | 0.610 |
Why?
|
| Urban Health Services | 2 | 2011 | 46 | 0.600 |
Why?
|
| Primary Health Care | 4 | 2025 | 378 | 0.520 |
Why?
|
| Urban Health | 2 | 2013 | 55 | 0.490 |
Why?
|
| Community-Based Participatory Research | 2 | 2013 | 38 | 0.460 |
Why?
|
| Telemedicine | 2 | 2025 | 225 | 0.450 |
Why?
|
| Data Collection | 2 | 2013 | 370 | 0.420 |
Why?
|
| Residence Characteristics | 2 | 2013 | 212 | 0.410 |
Why?
|
| Cities | 1 | 2013 | 57 | 0.390 |
Why?
|
| Education, Medical, Continuing | 2 | 2019 | 102 | 0.390 |
Why?
|
| Family Practice | 1 | 2013 | 73 | 0.370 |
Why?
|
| Community Health Workers | 1 | 2012 | 37 | 0.350 |
Why?
|
| Education | 1 | 2011 | 59 | 0.350 |
Why?
|
| HIV Infections | 5 | 2006 | 961 | 0.340 |
Why?
|
| Urban Population | 1 | 2012 | 234 | 0.330 |
Why?
|
| Students | 1 | 2012 | 179 | 0.320 |
Why?
|
| Physicians, Primary Care | 1 | 2011 | 109 | 0.320 |
Why?
|
| Internal Medicine | 1 | 2013 | 336 | 0.300 |
Why?
|
| AIDS Vaccines | 2 | 2006 | 15 | 0.300 |
Why?
|
| Hypertension | 1 | 2011 | 757 | 0.230 |
Why?
|
| Community Mental Health Services | 1 | 2025 | 21 | 0.220 |
Why?
|
| Chicago | 6 | 2019 | 1464 | 0.220 |
Why?
|
| Health Status | 1 | 2007 | 377 | 0.210 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2025 | 64 | 0.210 |
Why?
|
| Mental Health Services | 1 | 2025 | 77 | 0.210 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2024 | 96 | 0.200 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 373 | 0.200 |
Why?
|
| Hepatitis C | 1 | 2024 | 182 | 0.190 |
Why?
|
| Models, Educational | 2 | 2013 | 48 | 0.180 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2001 | 7 | 0.170 |
Why?
|
| Mental Disorders | 1 | 2025 | 455 | 0.160 |
Why?
|
| Asthma | 2 | 2015 | 1039 | 0.160 |
Why?
|
| Hepatitis B Vaccines | 1 | 1999 | 17 | 0.150 |
Why?
|
| Mycobacterium | 1 | 1999 | 19 | 0.150 |
Why?
|
| Bacterial Vaccines | 1 | 1999 | 44 | 0.150 |
Why?
|
| Mentoring | 1 | 2019 | 34 | 0.140 |
Why?
|
| Geriatrics | 1 | 2019 | 66 | 0.140 |
Why?
|
| Electronic Prescribing | 1 | 2016 | 10 | 0.120 |
Why?
|
| Infant | 5 | 2015 | 3220 | 0.120 |
Why?
|
| Population Health | 1 | 2016 | 33 | 0.120 |
Why?
|
| Pilot Projects | 2 | 2024 | 917 | 0.120 |
Why?
|
| Enterovirus D, Human | 1 | 2015 | 4 | 0.120 |
Why?
|
| Enterovirus Infections | 1 | 2015 | 25 | 0.120 |
Why?
|
| Community Health Centers | 1 | 2016 | 119 | 0.110 |
Why?
|
| Humans | 17 | 2025 | 93515 | 0.110 |
Why?
|
| Health Promotion | 1 | 2016 | 170 | 0.110 |
Why?
|
| HIV-1 | 2 | 2006 | 173 | 0.110 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 150 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2015 | 110 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 557 | 0.100 |
Why?
|
| Censuses | 1 | 2013 | 9 | 0.100 |
Why?
|
| Patient Dropouts | 1 | 2013 | 31 | 0.100 |
Why?
|
| Infant, Newborn | 3 | 2015 | 2479 | 0.100 |
Why?
|
| Emergencies | 1 | 2013 | 122 | 0.100 |
Why?
|
| Female | 10 | 2024 | 48702 | 0.090 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 128 | 0.090 |
Why?
|
| Child | 6 | 2015 | 7355 | 0.090 |
Why?
|
| Program Development | 1 | 2013 | 131 | 0.090 |
Why?
|
| Public Health | 1 | 2013 | 153 | 0.090 |
Why?
|
| Self Efficacy | 2 | 2024 | 58 | 0.090 |
Why?
|
| Self-Assessment | 1 | 2011 | 45 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2013 | 364 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2013 | 315 | 0.090 |
Why?
|
| Surveys and Questionnaires | 3 | 2019 | 2802 | 0.080 |
Why?
|
| Health Care Coalitions | 1 | 2011 | 9 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2015 | 3829 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2013 | 238 | 0.080 |
Why?
|
| Community-Institutional Relations | 1 | 2011 | 31 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2013 | 292 | 0.080 |
Why?
|
| Teaching | 1 | 2011 | 141 | 0.080 |
Why?
|
| Patient Preference | 1 | 2011 | 125 | 0.080 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2001 | 73 | 0.080 |
Why?
|
| Male | 8 | 2019 | 44557 | 0.080 |
Why?
|
| Lymphocyte Activation | 2 | 2005 | 797 | 0.080 |
Why?
|
| Patient Participation | 1 | 2011 | 229 | 0.080 |
Why?
|
| Disease Management | 1 | 2011 | 358 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 579 | 0.070 |
Why?
|
| HIV Antibodies | 2 | 2006 | 38 | 0.070 |
Why?
|
| Curriculum | 1 | 2013 | 594 | 0.070 |
Why?
|
| Adult | 4 | 2024 | 27918 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2715 | 0.060 |
Why?
|
| Case Management | 1 | 2007 | 29 | 0.060 |
Why?
|
| Health Services | 1 | 2007 | 56 | 0.060 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2006 | 37 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2011 | 822 | 0.060 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2005 | 18 | 0.060 |
Why?
|
| Vaccines, Synthetic | 1 | 2005 | 56 | 0.060 |
Why?
|
| Mucous Membrane | 1 | 2005 | 82 | 0.060 |
Why?
|
| Adolescent | 4 | 2015 | 9606 | 0.060 |
Why?
|
| Saliva | 1 | 2005 | 124 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2005 | 319 | 0.050 |
Why?
|
| Prenatal Care | 1 | 2024 | 80 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 492 | 0.050 |
Why?
|
| Medicaid | 1 | 2007 | 258 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2011 | 4560 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2024 | 364 | 0.040 |
Why?
|
| Measles virus | 1 | 2001 | 9 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2025 | 485 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2001 | 73 | 0.040 |
Why?
|
| Viral Load | 1 | 2001 | 154 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2006 | 1729 | 0.040 |
Why?
|
| Dapsone | 1 | 1999 | 11 | 0.040 |
Why?
|
| Skin Tests | 1 | 1999 | 46 | 0.040 |
Why?
|
| Hepatitis B Antibodies | 1 | 1999 | 16 | 0.040 |
Why?
|
| Administration, Cutaneous | 1 | 1999 | 61 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2001 | 322 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 1999 | 87 | 0.040 |
Why?
|
| Immunization | 1 | 1999 | 154 | 0.040 |
Why?
|
| Vaccination | 1 | 2001 | 304 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 1999 | 103 | 0.040 |
Why?
|
| Pregnancy | 1 | 2024 | 3147 | 0.030 |
Why?
|
| Medical Informatics | 1 | 2016 | 48 | 0.030 |
Why?
|
| Missouri | 1 | 2015 | 18 | 0.030 |
Why?
|
| Colorado | 1 | 2015 | 39 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2015 | 39 | 0.030 |
Why?
|
| Cough | 1 | 2015 | 56 | 0.030 |
Why?
|
| Dyspnea | 1 | 2015 | 86 | 0.030 |
Why?
|
| Fever | 1 | 2015 | 122 | 0.030 |
Why?
|
| Crowding | 1 | 2013 | 6 | 0.030 |
Why?
|
| Illinois | 1 | 2015 | 520 | 0.030 |
Why?
|
| Health Services Misuse | 1 | 2013 | 20 | 0.030 |
Why?
|
| Telephone | 1 | 2013 | 36 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 2013 | 57 | 0.020 |
Why?
|
| Treatment Refusal | 1 | 2013 | 68 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2013 | 188 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 423 | 0.020 |
Why?
|
| Critical Care | 1 | 2015 | 444 | 0.020 |
Why?
|
| Health Personnel | 1 | 2013 | 234 | 0.020 |
Why?
|
| Organizational Case Studies | 1 | 2011 | 24 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2011 | 47 | 0.020 |
Why?
|
| Parents | 1 | 2013 | 292 | 0.020 |
Why?
|
| Motivation | 1 | 2013 | 310 | 0.020 |
Why?
|
| Universities | 1 | 2011 | 150 | 0.020 |
Why?
|
| Hospitalization | 1 | 2015 | 937 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 20434 | 0.020 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2006 | 16 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 3830 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2006 | 183 | 0.010 |
Why?
|
| Breast Feeding | 1 | 2006 | 100 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 5410 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 7061 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 6930 | 0.010 |
Why?
|
| United States | 1 | 2015 | 7622 | 0.010 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1999 | 16 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1999 | 307 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 27573 | 0.010 |
Why?
|